FDA Narcotic Treatment Programs Directory PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download FDA Narcotic Treatment Programs Directory PDF full book. Access full book title FDA Narcotic Treatment Programs Directory by United States. Food and Drug Administration. Download full books in PDF and EPUB format.
Author: United States. Food and Drug Administration
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 184
Get Book Here
Book Description
Author: United States. Food and Drug Administration
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 184
Get Book Here
Book Description
Author: United States. Food and Drug Administration
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 161
Get Book Here
Book Description
Author: United States. Food and Drug Administration. Regulatory Management Branch
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 208
Get Book Here
Book Description
Author: Committee on Federal Regulation of Methadone Treatment
Publisher: National Academies Press
ISBN: 0309598621
Category : Medical
Languages : en
Pages : 251
Get Book Here
Book Description
For nearly three decades, methadone hydrochloride has been the primary means of treating opiate addiction. Today, about 115,000 people receive such treatment, and thousands more have benefited from it in the past. Even though methadone's effectiveness has been well established, its use remains controversial, a fact reflected by the extensive regulation of its manufacturing, labeling, distribution, and use. The Food and Drug Administration regulates the safety and effectiveness of methadone, as it does for all drugs, and the Drug Enforcement Administration regulates it as a controlled substance. However, methadone is also subjected to a unique additional tier of regulation that prescribes how and under what circumstances it may be used to treat opiate addiction. Federal Regulation of Methadone Treatment examines current Department of Health and Human Services standards for narcotic addiction treatment and the regulation of methadone treatment programs pursuant to those standards. The book includes an evaluation of the effect of federal regulations on the provision of methadone treatment services and an exploration of options for modifying the regulations to allow optimal clinical practice. The volume also includes an assessment of alternatives to the existing regulations.
Author:
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 128
Get Book Here
Book Description
Author: U.S. Department of Health and Human Services
Publisher: Lulu.com
ISBN: 1794763538
Category : Reference
Languages : en
Pages : 84
Get Book Here
Book Description
The Federal Guidelines for Opioid Treatment Programs (Guidelines) describe the Substance Abuse and Mental Health Services Administration's (SAMHSA) expectation of how the federal opioid treatment standards found in Title 42 of the Code of Federal Regulations Part 8 (42 CFR � 8) are to be satisfied by opioid treatment programs (OTPs). Under these federal regulations, OTPs are required to have current valid accreditation status, SAMHSA certification, and Drug Enforcement Administration (DEA) registration before they are able to administer or dispense opioid drugs for the treatment of opioid addiction.
Author:
Publisher:
ISBN:
Category : Veterinary drugs
Languages : en
Pages : 144
Get Book Here
Book Description
Author: Lynne C. McArthur
Publisher: DIANE Publishing
ISBN: 0788139509
Category :
Languages : en
Pages : 188
Get Book Here
Book Description
Provides basic information to direct care providers at the state level as they address Fed. regulatory procedures for the development and management of narcotic treatment programs. Presents information about state and Fed. application requirements for program approval and compliance with ongoing regulatory standards. Also serves as a reference for Fed. agencies and state authorities involved in program oversight, management, and technical assistance. Includes FDA and DEA forms and regulations, confidentiality reg's., standard definitions used during application and monitoring, investigational new drug application reg's.
Author: Substance Abuse Mental Health Services Administration/SAMHSA (U.S.)
Publisher: Government Printing Office
ISBN: 0160943752
Category : Medical
Languages : en
Pages : 398
Get Book Here
Book Description
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat opioid use disorder (OUD)—methadone, naltrexone, and buprenorphine—and provides guidance for healthcare professionals and addiction treatment providers on appropriate prescribing practices for these medications and effective strategies for supporting the patients utilizing medication for the treatment of OUD. The goal of treatment for opioid addiction or OUD is remission of the disorder leading to lasting recovery. Recovery is a process of change through which individuals improve their health and wellness, live self-directed lives, and strive to reach their full potential. This TIP also educates patients, families, and the general public about how OUD medications work and the benefits they offer. Related products: Medication-Assisted Treatment of Opioid Use Disorder: Pocket Guide A Shared Burden: The Military and Civilian Consequences of Army Pain Management Since 2001 Click our Alcoholism, Smoking & Substance Abuse collection to find more resources on this topic.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309486483
Category : Medical
Languages : en
Pages : 175
Get Book Here
Book Description
The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.
